Verhuizen Anke BV SRL
Verhuizen Anke BV reported total assets of 27,853 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jan 2026).
The score of Verhuizen Anke BV shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Verhuizen Anke BV's annual accounts
| 2025 | |
|---|---|
| Net result | 6,080 € |
| Equity | 11,080 € |
| Cash | 3,842 € |
| EBITDA | 10,069 € |
| Total assets | 27,853 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 28 Jan 2026
Verhuizen Anke BV's financial analysis
- Solvency39.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Verhuizen Anke BV
Verhuizen Anke BV's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1010.891.933
- VAT number
- BE1010891933
- Peppol
- Registered · 0208:1010891933 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Jun 2024
- Registered office
- 2290 Vorselaar
- Latest accounts
- 2025 · filed on 28 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Verhuizen Anke BV (SRL) has been based in Vorselaar since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 6,080 € and equity of 11,080 €; its revenue is not published. Its solvency stands at 39.8%, below the median of its sector (44.2%).
Companies similar to Verhuizen Anke BV
Companies in the same business, of comparable size and area, outside its group.
- Laphare Retail sale of pharmaceutical products Mettet · balance sheet 49,090 €
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
- Pharmaxus Retail sale of pharmaceutical products Zandhoven · balance sheet 25,186 €
- Pharmanatuur Retail sale of pharmaceutical products Affligem · balance sheet 51,561 €
- Bossiroy Pharma Retail sale of pharmaceutical products Uccle · balance sheet 65,695 €
- Smilla Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet 70,168 €
- Pharmacie Marievoet Retail sale of pharmaceutical products Auderghem · balance sheet 60,288 €
- Farmecha Services Retail sale of pharmaceutical products Bornem · balance sheet 72,929 €
Frequently asked questions about Verhuizen Anke BV
What is the revenue of Verhuizen Anke BV?
Verhuizen Anke BV files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Verhuizen Anke BV?
In Belgium, the VAT number is the company number prefixed with BE: BE1010891933 for Verhuizen Anke BV, if the company is VAT-registered. Its company number (CBE) is 1010.891.933.
Where is the registered office of Verhuizen Anke BV?
According to the CBE register, the registered office of Verhuizen Anke BV is in 2290 Vorselaar.
What is the equity of Verhuizen Anke BV?
At the close of the 2025 financial year, the equity of Verhuizen Anke BV amounts to 11,080 €, a solvency of 39.8% of total assets.
Who manages Verhuizen Anke BV?
The register lists 1 active mandates at Verhuizen Anke BV. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Verhuizen Anke BV
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →